Previous 10 | Next 10 |
Kahn Brothers’ 13F portfolio value increased from $698M to $710M this quarter. Pfizer, VOXX International, and ViewRay were increased substantially during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~44% of the 13F...
Victoria's Secret is a spin-off from L Brands. The company is trading for an extremely attractive valuation. Spin-off companies tend to outperform the market. For further details see: Spin-Off Companies Outperforms The Market The Case For Victoria's Secret
Organon (NYSE: OGN), will release its third quarter 2021 financial results on November 11, 2021, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET. Interested parties may access the live call via webcast on the Organon website at https://www.orga...
This Buffett holdings list from Kiplinger first appeared 8/17/21 online. YCharts and Dogs of The Dow also track this Buffett/Berkshire Batch. Here is your update from 10/13/21 YCharts data. 29 of 44 current Berkshire-Hathaway-owned stocks pay dividends. As of 10/13/21 the top-ten rang...
Website aims to provide information on the fertility journey including, but not limited to, preparing for conversations with specialists, highlighting potential treatment options and navigating cost and coverage Organon (NYSE: OGN) today announced the launch of a new website...
Postpartum hemorrhage is one of the most common complications of birth i Organon (NYSE: OGN), a global women’s health company, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for technological updates to the Jada&...
Moderna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX), and Regeneron Pharmaceuticals (NASDAQ:REGN), respectively, the first, second, and fifth best performing pharma stocks of Q3 have not continued that positive momentum early in Q4. Since Oct. 1 through the close of trading today, Moderna is do...
It's time to look at the September 2021 period and look at how the portfolio performed. We saw an exciting dip, and as a result, significant buying opportunities. I took advantage and put almost $13,000 to work. Thanks to a truly massive extraordinary dividend from Swedish Handels...
Organon is a new company listed on June after the spin-off from Merck. Spin-off companies tend to outperform the broad market. In addition, the company has initiated its first dividend so dividend growth and income investors will enjoy it too. For further details see: Or...
Organon wants to help women take control of their birth control Canada NewsWire Building on vision to create a better and healthier every day for every woman, Organon wants to empower women so they can be in full control of their sexual health KIRKLAND, QC , ...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...